Construction Business Review Conferences
The PharmaMarketing Summit strengthens future-ready commercial strategy by bringing together senior pharma marketing leaders to share actionable insight, challenge legacy approaches and build high-value partnerships. Through focused dialogue on launch excellence, omnichannel engagement, data and AI adoption, and evolving HCP and patient expectations, we help decision-makers improve brand performance, accelerate execution, enhance decision confidence and deliver measurable commercial impact in a complex, regulated market.
The American Biomanufacturing Summit has a rich history as an exclusive platform for biopharma and biotech executives - and as a flagship annual event, it remains a premier biomanufacturing event built for high-level, in-person knowledge exchange and solution exploration.
Welcome to the ADC Development Summit 2027, uniting drug developers, process chemists, manufacturing leaders, clinical teams, and patent counsel to advance antibody-drug conjugate therapies. Tumor resistance and off-target toxicity narrow the therapeutic index even as approvals accelerate, and manufacturing and characterization demands keep rising. The field is responding with new payloads and formats, site-specific conjugation, stronger manufacturing, and clearer regulatory and IP strategy.
The AI in Medical Affairs conference examines how artificial intelligence is being applied across medical strategy, evidence generation, scientific communications and field medical operations within pharmaceutical, biotechnology and medical device organizations. Its audience includes medical affairs leaders, digital strategists, data specialists and clinical professionals navigating AI adoption, workforce upskilling, data synthesis and the need to deploy compliant solutions that deliver measurable value. Life Sciences Review’s coverage of scientific innovation, regulatory demands and operational change across pharmaceuticals, biotechnology, medical devices and diagnostics provides a broader context for these developments. Its reporting can follow how generative AI, data-driven decision-making and automation are being implemented in medical functions while examining governance, compliance and practical adoption challenges. Such coverage gives the publication’s professiona
The PharmaMarketing Summit returns on January 21-22, 2027 at the Four Seasons Hotel Westlake Village, California, bringing together America's foremost pharmaceutical commercial leaders to redefine brand performance in the AI era. Senior executives including Anthony Pugliese, Vice President of Obesity Intelligence & Analytics at Amgen, Sonia Thomas, Head of Marketing Strategy & Transformation at Conexeu Sciences Inc., and Jeremy Whitelock, Vice President of Global Value and Access at Kailera Therapeutics, will share proven frameworks for launch excellence, HCP engagement, and market access strategy. This invitation-only gathering offers an unmatched environment for peer exchange and strategic alliance building. Secure your place at the forefront of pharma marketing innovation today.
The Evolution Summit equips senior clinical leaders to strengthen trial execution amid rapidly evolving technology, regulatory expectations and development models. Through executive case studies, peer benchmarking and closed-door discussion, delegates examine practical AI implementation, patient-centered trial design, ICH E6(R3), global trial strategy and evolving site and CRO partnerships. The program enables leaders to challenge established operating models, identify opportunities to improve speed, quality and efficiency and prepare their organizations for emerging approaches including Real-Time Clinical Trials.
Designing the AI-Enabled Life Sciences Workforce Summit returns as the only industry-specific forum dedicated to helping CHROs, strategic HR, workforce strategy, and transformation leaders move from AI ambition to demonstrable enterprise-wide ROI. Join CHROs, Heads of People Strategy, Talent, Analytics, Organizational Effectiveness, Transformation, and Workforce Strategy to benchmark and pressure-test your thinking.
Life science organizations developing cell therapies for autoimmune diseases are under increasing pressure to translate promising clinical results into scalable, commercially viable treatments. While early proof-of-concept studies have demonstrated the transformative potential of approaches such as CAR-T, NK, Treg, MSC, and emerging in vivo therapies, significant challenges remain in target selection, manufacturing scalability, safety management, regulatory alignment, and patient accessibility. As clinical datasets mature and the field expands beyond oncology, developers must establish clear strategies to accelerate development, demonstrate long-term value, and deliver meaningful outcomes for patients. The 4th Cell Therapy for Autoimmune Disease Summit brings together industry leaders to share real-world insights, benchmark best practices, and foster collaborations that will help advance the next generation of autoimmune cell therapies from clinical promise to widespread patient imp
The American Pharma Manufacturing & Outsourcing Summit is a premier executive-level pharma manufacturing and pharma outsourcing conference, bringing together 150+ senior leaders from pharmaceutical manufacturers and leading solution providers.
U.S Biotech Day is an international premier event for life science leaders, innovators, investors and service providers. Our mission is to unite the U.S’s vibrant biotech ecosystem, spanning world-class research, dynamic startups, big pharma, and visionary investors, to drive breakthrough partnerships. Join us to discover new opportunities, forge strategic alliances, and help shape the next era of biotech success in the U.S and the world.
